Related Experiment Video
Updated: Jun 8, 2026
11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
Intravenous and subcutaneous tramadol for inguinal herniorrhaphy: comparative study
Talita Oliveira Dias dos Santos1, Tomaz Gonzalez Estrela, Vera Lucia Fernandes de Azevedo
1Hospital Santo Antonio, CET Associação Obras Sociais Irmã Dulce Salvador, BA.
Revista Brasileira De Anestesiologia
|September 25, 2010
Summary
Subcutaneous and intravenous tramadol offer similar postoperative pain relief and side effect profiles for inguinal herniorrhaphy patients. This study found no significant differences in nausea, vomiting, or analgesia quality between the two administration methods.
Area of Science:
- Anesthesiology
- Pharmacology
- Surgical Recovery
Background:
- Inguinal herniorrhaphy is a common surgical procedure in men.
- Postoperative nausea and vomiting (PONV) are significant concerns impacting patient discharge after anesthesia.
- Tramadol is an analgesic used for postoperative pain, but its side effect profile, including PONV, can be variable.
Purpose of the Study:
- To compare the incidence of postoperative nausea and vomiting (PONV) between subcutaneous and intravenous tramadol.
- To evaluate and compare the quality of postoperative analgesia provided by subcutaneous versus intravenous tramadol.
- To assess the safety and efficacy of different tramadol administration routes in patients undergoing inguinal herniorrhaphy.
Main Methods:
- A prospective study involving 30 patients undergoing inguinal herniorrhaphy.
- Patients were randomized to receive either subcutaneous (Group C) or intravenous (Group V) tramadol at a dose of 1.5 mg/kg.
- All patients received continuous epidural anesthesia with levobupivacaine; data on analgesia quality and PONV were collected over eight hours.
Main Results:
- No statistically significant differences were found between the subcutaneous and intravenous tramadol groups regarding anthropometric data.
- The quality of postoperative analgesia was comparable between the two tramadol administration groups.
- Incidence of postoperative nausea and vomiting did not significantly differ between patients receiving subcutaneous versus intravenous tramadol.
Conclusions:
- Subcutaneous and intravenous administration of tramadol yield comparable outcomes for postoperative analgesia quality in inguinal herniorrhaphy.
- Neither administration route demonstrated a significant advantage in reducing the incidence of postoperative nausea and vomiting.
- The findings suggest that both subcutaneous and intravenous tramadol are viable options for postoperative pain management in this patient population.